Market revenue in 2023 | USD 434.2 million |
Market revenue in 2030 | USD 676.5 million |
Growth rate | 6.5% (CAGR from 2023 to 2030) |
Largest segment | Glucose testing |
Fastest growing segment | Glucose testing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Glucose testing, A1C testing, Direct LDL testing, Lipid panel testing, Prostate-specific antigen testing, COVID-19 testing, BUN testing, Vitamin D testing, Thyroid-stimulating hormone testing, Serum Nicotine / Cotinine testing, High sensitivity CRP testing, Testosterone testing, ALT testing, Cortisol testing, Creatinine testing, AST testing, Other blood tests |
Key market players worldwide | Abbott Laboratories, Roche Holding AG ADR, Bio-Rad Laboratories Inc, BioMerieux SA, Quest Diagnostics Inc, Biomerica Inc, Becton Dickinson & Co, Siemens Healthineers AG ADR, Danaher Corp, Trinity Biotech PLC ADR |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to blood testing market will help companies and investors design strategic landscapes.
Glucose testing was the largest segment with a revenue share of 14.92% in 2023. Horizon Databook has segmented the Turkey blood testing market based on glucose testing, a1c testing, direct ldl testing, lipid panel testing, prostate-specific antigen testing, covid-19 testing, bun testing, vitamin d testing, thyroid-stimulating hormone testing, serum nicotine / cotinine testing, high sensitivity crp testing, testosterone testing, alt testing, cortisol testing, creatinine testing, ast testing, other blood tests covering the revenue growth of each sub-segment from 2018 to 2030.
Based on a research paper, causative agents such as lack of physical activity, smoking, and obesity are some of the common factors leading to a high incidence of diabetes and hypertension.
According to Institute for Health Metrics and Evaluation, ischemic heart disease, stroke, chronic kidney disease, and diabetes are among the top 10 causative diseases for premature death in the nation.
Additional research from NCBI also suggests that there is a high burden of cardiovascular diseases in the country, which is estimated to rise at a steep rate in the near future. Further research from the same source also indicates that the economic burden of cardiovascular diseases in the nation was estimated at USD 10.2 billion in 2016.
Horizon Databook provides a detailed overview of country-level data and insights on the Turkey blood testing market , including forecasts for subscribers. This country databook contains high-level insights into Turkey blood testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account